On November 10, 2018, a Myeloma Crowd Round Table meeting was held in Buffalo, NY featuring four myeloma experts, including:
Myeloma Round Table Introduction
Dr. Hillengass introduces the speakers for the Round Table and welcomes the patients present.
The Basics of Multiple Myeloma
Dr. Morie Gertz of the Mayo Clinic teaches about the basics of myeloma. He relates your bone marrow to a garden and describes how myeloma affects the body, what important blood numbers you need to know as a patient, what to bring to a second opinion consultation, and why transplant isn’t a cure.
Myeloma Genetics: Not Just for Scientists
Dr. Donna Reece of Princess Margaret Hospital and University of Toronto explains myeloma genetics, how myeloma staging has evolved over time, types of genetic testing, high-risk genetic features and how high-risk disease can be treated.
Myeloma Transplant and Maintenance
Dr. Philip McCarthy of Roswell Comprehensive Cancer Center explains the essentials of understanding transplant and maintenance therapy, gives an overview of the history of myeloma therapies, and dives into recent studies showing the benefit of transplant and new maintenance therapies to individuals with myeloma.
Myeloma Expert Panel and Q&A – Morning Session
Myeloma experts Drs. Hillengass, Reece, McCarthy and Gertz answer patient questions from the audience during the live Q&A discussion panel. Topics covered include:
Imaging in Myeloma
Dr. Jens Hillengass of Roswell Comprehensive Cancer Center walks patients through the different types of imaging used in myeloma, compares and contrasts the advantages and disadvantages of each kind, and talks about future advances in myeloma imaging.
Myeloma Maintenance and Future Therapies
Dr. Philip McCarthy of Roswell Comprehensive Cancer Center talks maintenance and consolidation treatment, treating relapsed disease and upcoming new therapies for multiple myeloma.
Frequently Asked Questions in Myeloma
Dr. Morie Gertz of the Mayo Clinic Talks about when to treat myeloma, the limitations of staging, median survival, transplant vs. chemotherapy, the importance of participating in clinical trials and how close are we to targeted therapy in myeloma.
Myeloma Expert Panel and Q&A – Afternoon Session
Myeloma experts Drs. Hillengass, McCarthy and Gertz answer patient questions from the audience during the live Q&A discussion panel. Topics covered include:
Thanks to our Sponsors
about the author
Erika Johnson
Myeloma Crowd Editorial Contributor, Nursing student, and cancer advocate.
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.